1 |
Lv J, Xing L, Zhong X, Li K, Liu M, Du K. Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents. Biomedicine & Pharmacotherapy 2023;162:114583. [DOI: 10.1016/j.biopha.2023.114583] [Reference Citation Analysis]
|
2 |
Huang P, Liu M, Zhang J, Zhong X, Zhong C. YTHDF1 Attenuates TBI-Induced Brain-Gut Axis Dysfunction in Mice. Int J Mol Sci 2023;24. [PMID: 36835655 DOI: 10.3390/ijms24044240] [Reference Citation Analysis]
|
3 |
Mao Y, Jiang F, Xu XJ, Zhou LB, Jin R, Zhuang LL, Juan CX, Zhou GP. Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway. Int J Biol Sci 2023;19:593-609. [PMID: 36632449 DOI: 10.7150/ijbs.78348] [Reference Citation Analysis]
|
4 |
Yakout DW, Shroff A, Allen ZD, Nazarko TY, Mabb AM. A differential effect for tau isoforms and mutants in decreasing the stability of Arc.. [DOI: 10.1101/2022.12.15.520620] [Reference Citation Analysis]
|
5 |
Fang J, Chen Z, Lai X, Yin W, Guo Y, Zhang W, Ma J, Li G, Zhang L. Mesenchymal stem cells-derived HIF-1α-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic β cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy. Bioorganic Chemistry 2022;129:106194. [DOI: 10.1016/j.bioorg.2022.106194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
6 |
Huang P, Liu M, Zhang J, Zhong X, Zhong C. The Potential Role of m6A in the Regulation of TBI-Induced BGA Dysfunction. Antioxidants 2022;11:1521. [DOI: 10.3390/antiox11081521] [Reference Citation Analysis]
|